China Underground > All the latest news about China > China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …

Subscribe to China Underground and get the free magazine 'Planet China'

* indicates required

View previous campaigns.

By clicking Sign Up, you agree to our terms and conditions.

You can unsubscribe at any time by clicking the link in the footer of our emails.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Previous

Canada’s Trudeau, Cabinet Abstain From China Genocide Vote

Hong Kong’s Carrie Lam defends China’s plans to ensure ‘patriots’ lead city

Next

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.